It offers various commercial, consumer, mortgage, and private banking services and products; cash management services; deposit and annuity products; and brokerage services, as well as sells variable annuities. EnLink Midstream, LLC is given 2 buy-equivalent recommendations, 0 sells and 14 holds. Goldman Sachs Group Incorporated has invested 0% in Diplomat Pharmacy, Inc. (NYSE:DPLO) on Wednesday, October 21 with "Buy" rating. The Connecticut-based Matarin Capital Management Llc has invested 0.92% in the stock. The company's past year sales total was 1.14 Million. Of those insider trades, 63,146 shares of Diplomat Pharmacy, Inc. were purchased and 0 shares were sold. It has underperformed by 57.18% the S&P500. It was reported on Jan, 11 by Barchart.com. We have $27.49 PT which if reached, will make NYSE:DPLO worth $113.52M more.
Diplomat Pharmacy, Inc. (DPLO) has the market capitalization of $1.56 Billion. The company has market cap of $1.83 billion.
Diplomat Pharmacy, Inc (Diplomat) operates a specialty pharmacy business, which stocks, dispenses and distributes prescriptions for various biotechnology and specialty pharmaceutical manufacturers. It has a 221.62 P/E ratio. The Company operates through specialty pharmacy services segment.
Analysts await Diplomat Pharmacy, Inc. The firm is expected to announce its next earnings report on Tuesday, February 27th. While in the same Quarter Previous year, the Actual EPS was $0.15. The company reported $0.25 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.15 by $0.10.
Among 13 analysts covering Diplomat Pharmacy (NYSE:DPLO), 5 have Buy rating, 1 Sell and 7 Hold. Therefore 44% are positive. Diplomat Pharmacy has a one year low of $12.25 and a one year high of $38.94. Currently, the stock has a 1 Year Price Target of $21. The firm's revenue for the quarter was down 4.8% on a year-over-year basis. Through this figure traders can analyze that DPLO show whether or not a stock now most active and standing in buying side or sell side. The stock has "Buy" rating by Instinet on Wednesday, January 3. This volatility measure use for multipurpose in judging the underlying price momentum as well as the rate of change in DPLO's price. Mizuho has "Neutral" rating and $17.0 target. The firm earned "Buy" rating on Monday, November 9 by Nomura. UBS initiated Diplomat Pharmacy, Inc. The company was upgraded on Wednesday, October 14 by Bank of America. Raymond James downgraded the shares of DPLO in report on Thursday, November 3 to "Market Perform" rating.
Investors sentiment decreased to 1.44 in Q3 2017. Its down 0.83, from 2.27 in 2017Q2. It turned negative, as 22 investors sold Diplomat Pharmacy, Inc. shares while 37 reduced holdings. Piedmont Investment Advisors LLC acquired a new stake in Diplomat Pharmacy during the third quarter worth about $216,000. California Public Employees Retirement System has 171,664 shares for 0.01% of their portfolio. Cambridge Invest reported 1.10 million shares stake. (NYSE:SF). Boston Limited Liability Com owns 107,185 shares. Tekla Mngmt Lc accumulated 461,712 shares or 0.34% of the stock. Commercial Bank Of Montreal Can reported 6,994 shares. It worsened, as 21 investors sold SF shares while 80 reduced holdings. Diplomat Pharmacy had a return on equity of 8.30% and a net margin of 0.18%. (NYSE:DPLO). Envestnet Asset holds 13,105 shares or 0% of its portfolio. Deutsche Natl Bank Ag stated it has 93,664 shares or 0% of all its holdings.
Cortina Asset Management Llc holds 1.37% of its portfolio in Diplomat Pharmacy, Inc. for 1.62 million shares. (NYSE:DPLO) advice adding it to buy candidate list. Fdx Advsr stated it has 23,849 shares. Moreover, State Of Tennessee Treasury Department has 0% invested in Diplomat Pharmacy, Inc. About 408,797 shares traded or 1.09% up from the average. It is down 0.00% since January 11, 2017 and is. It has outperformed by 12.01% the S&P500. First Bancshares Of Omaha holds 97,100 shares or 0.29% of its portfolio. Old Bancorporation In owns 17,937 shares or 0.02% of their USA portfolio. Institutional investors and hedge funds own 72.21% of the company's stock.
Channing Capital Management Llc increased Stifel Fin Corp (SF) stake by 10.86% reported in 2017Q3 SEC filing.
Whereas they predicted High and Low Earnings Estimate as $0.18 and $0.15 respectively. IBKC's profit will be $68.42 million for 16.23 P/E if the $1.27 EPS becomes a reality. Its up 1.25% from 1.41M shares previously.
Ratings analysis reveals 50% of IberiaBank's analysts are positive. Five equities research analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the stock. DPLO was included in 2 notes of analysts from November 3, 2016. The rating was initiated by JMP Securities on Thursday, February 2 with "Mkt Perform". As per Tuesday, May 23, the company rating was downgraded by Instinet. The rating was maintained by FBR Capital with "Outperform" on Wednesday, September 7.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.
- Synovus Financial Corp. (SNV) Shares Sold by Capital City Trust Co. FL
- Bullish Two Hundred Day Moving Average Cross - ARI
- Lobbying for a deal on DACA in Washington
- Electro Scientific Industries, Inc. (ESIO) Stock Price Up 5.2% on Earnings Beat
- Sells 592 Shares of Procter & Gamble Company (The) (PG)
- There was a combination of confusion and fury after Antonio Conte decision
- Serena Williams Talks Medical Ordeal Following Daughter's Birth
- Stryker (SYK) EPS Estimated At $1.95; Isramco (ISRL) SI Decreased By 12.86%
- Brookdale Senior Living Inc. (BKD), Sucampo Pharmaceuticals, Inc. (SCMP)
- Analysts Showing Optimistic Trends For Synergy Pharmaceuticals, Inc. (SGYP)